| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.11B | +16.6% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | +230.4% |
| Gross margin | 56.0% | Net margin 24.2% |
| Revenue Q/Q | -31.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 44.0% |
| R&D | ¥0.01B | 10.2% |
| SG&A | ¥0.01B | 12.7% |
| Tax & other | ¥0.00B | 2.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
昊帆生物 ・ 仁信新材 ・ 宏景科技 ・ 溯联股份 ・ 星源卓镁 ・ 英特科技 ・ 华人健康 ・ 安培龙 ・ 协昌科技 ・ 阿莱德 ・ 波长光电 ・ 世纪恒通
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies